Updates from FDA

After deadly wildfires ripped through Lahaina, located on the western edge of Maui, pharmacists quickly mobilized to get displaced residents their medications.

Loren Bonner

Taking into consideration specific recommendations on several new classes of medications as well as placing an emphasis on social determinants of health, the American Heart Association, the American College of Cardiology, and other associations issued updated guidelines on managing chronic coronary disease.

Loren Bonner

In August 2023, FDA approved zuranolone (Zurzuvae), the first oral medication for postpartum depression. Until now, the only treatment specifically for postpartum depression was brexanolone, a 60-hour I.V. infusion administered in a health care facility.

Sonya Collins

Over a decade has passed since the first states, Colorado and Washington, legalized cannabis for recreational use. Another 5 years have gone by since the Farm Bill allowed for the sale of hemp and its derived products. And over the past several years, many states have passed legislation allowing cannabis to be used medically. But questions remain.

Ariel L. Clark, PharmD